recall
saveSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)
community read0 votes
Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4 — Reason: Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D. — Status: Ongoing
view source ↗Data sources
last refreshed 5m ago
Found something off?
same company · ±60 days · 6
- recallSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)Jan 21, 2026
- approvalOLANZAPINE — FDA approvalJan 23, 2026
- approvalZYPREXA (OLANZAPINE) — FDA approvalJan 30, 2026
- approvalZYPREXA (OLANZAPINE) — FDA approvalJan 30, 2026
- recallSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls II)Feb 11, 2026
- approvalOLANZAPINE — FDA approvalMar 5, 2026
comments(0)
5-min edit window · permanent after that